PHASE 2 STUDY OF TELAPREVIR ADMINISTERED Q8H OR Q12H WITH PEGINTERFERON-ALFA-2A OR -ALFA-2B AND RIBAVIRIN IN TREATMENT-NAiVE SUBJECTS WITH GENOTYPE 1. HEPATITIS C: WEEK 4 INTERIM RESULTS (vol 48, pg 4, 2008)

被引：0
|
作者：
Forns, X. [1 ]
Marcellin, P. [2 ]
Goeser, T. [3 ]
Ferenci, P. [4 ]
Nevens, F. [5 ]
Carosi, G. [6 ]
Drenth, J. P. [7 ]
De Backer, K. [8 ]
van Heeswijk, R. [8 ]
Vangeneugden, T. J. [8 ]
Picchio, G. [9 ]
Beumont-Mauviel, M. [8 ]
机构：
[1] Univ Barcelona, Liver Unit, Barcelona, Spain
[2] Hop Beaujon, Clichy, France
[3] Klinikum Univ Koln, Cologne, Germany
[4] Med Univ Vienna, Dept Internal Med 3, Vienna, Austria
[5] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Louvain, Belgium
[6] Univ Brescia, Clin Infect & Trop Dis, Brescia, Italy
[7] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[8] Tibotec BVBA, Mechelen, Belgium
[9] Tibotec Inc, Yardley, PA USA
来源：
HEPATOLOGY | 2008年 / 48卷 / 06期
关键词：
D O I：
10.1002/hep.22702
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：2093 / 2093
页数：1
相关论文
共 50 条
  • [11] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: INTERIM RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Vangeneugden, T.
    Picchio, G.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S22 - S22
  • [12] Boceprevir Plus Peginterferon Alfa-2B and Ribavirin in Russian Patients With Hepatitis C Virus Genotype 1 Infection: Treatment Week 8 Interim Analysis
    Isakov, Vasily
    Nikitin, Igor
    Chulanov, Vladimir P.
    Ogurtsov, Pavel P.
    Lukyanova, Ekaterina
    Long, Jianmin
    Wahl, Janice
    Helmond, Frans A.
    HEPATOLOGY, 2013, 58 : 1140A - 1140A
  • [13] Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study
    Norio Hayashi
    Makoto Nakamuta
    Tetsuo Takehara
    Hiromitsu Kumada
    Akiko Takase
    Anita Yee Mei Howe
    Steven W. Ludmerer
    Niloufar Mobashery
    Journal of Gastroenterology, 2016, 51 : 390 - 403
  • [14] Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study
    Hayashi, Norio
    Nakamuta, Makoto
    Takehara, Tetsuo
    Kumada, Hiromitsu
    Takase, Akiko
    Howe, Anita Yee Mei
    Ludmerer, Steven W.
    Mobashery, Niloufar
    JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 390 - 403
  • [15] VX-222/TELAPREVIR IN COMBINATION WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HCV PATIENTS TREATED FOR 12 WEEKS: ZENITH STUDY, SVR12 INTERIM ANALYSIS
    Nelson, David R.
    Gane, Edward J.
    Jacobson, Ira M.
    Di Bisceglie, Adrian M.
    Alves, Katia
    Koziel, Margaret J.
    De Souza, Cynthia
    Kieffer, Tara L.
    George, Shelley
    Rosario, Maria
    Kauffman, Robert S.
    Sulkowski, Mark S.
    HEPATOLOGY, 2011, 54 : 1435A - 1435A
  • [16] Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C
    Neumann, Avidan U.
    Pianko, Stephen
    Zeuzem, Stefan
    Yoshida, Eric M.
    Benhamou, Yves
    Mishan, Moshe
    McHutchison, John G.
    Pulkstenis, Erik
    Subramanian, G. Mani
    JOURNAL OF HEPATOLOGY, 2009, 51 (01) : 21 - 28
  • [17] RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS
    Benhamou, Y.
    Moussalli, J.
    Ratziu, V.
    Lebray, P.
    Gysen, V.
    de Backer, K.
    Ghys, A.
    van Heeswijk, R.
    Vangeneugden, I.
    Picchio, G.
    Beumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S6 - S6
  • [18] HCV SPRINT-1 FINAL RESULTS: SVR 24 FROM A PHASE 2 STUDY OF BOCEPREVIR PLUS PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN IN TREATMENT-NAIVE SUBJECTS WITH GENOTYPE-1 CHRONIC HEPATITIS C
    Kwo, P.
    Lawitz, E.
    McCone, J.
    Schiff, E.
    Vierling, J.
    Pound, D.
    Davis, M.
    Galati, J.
    Gordon, S.
    Ravendhran, N.
    Rossaro, L.
    Anderson, F.
    Jacobson, I.
    Rubin, R.
    Koury, K.
    Brass, C.
    Chaudhri, E.
    Albrecht, J.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S4 - S4
  • [19] ONCE DAILY NARLAPREVIR (SCH 900518) IN COMBINATION WITH PEGINTRON™ (PEGINTERFERON ALFA-2B)/RIBAVIRIN FOR TREATMENT-NAiVE SUBJECTS WITH GENOTYPE-1 CHC: INTERIM RESULTS FROM NEXT-1, A PHASE 2A STUDY
    Vierling, John M.
    Poordad, Fred
    Lawitz, Eric
    Ghalib, Reem H.
    Lee, William M.
    Ravendhran, Natarajan
    Galati, Joseph S.
    Bacon, Bruce R.
    Flamm, Steven L.
    Balart, Luis A.
    Freilich, Bradley
    Schiff, Eugene R.
    Jacobson, Ira M.
    Kwo, Paul Y.
    Gordon, Stuart C.
    Sulkowski, Mark S.
    Boparai, Navdeep
    Chaudhri, Eirum I.
    Brass, Clifford
    Hughes, Eric A.
    Albrecht, Janice K.
    HEPATOLOGY, 2009, 50 (06) : 3A - 4A
  • [20] ACTIVITY OF TELAPREVIR ALONE OR IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 2 AND 3 HEPATITIS-C PATIENTS: FINAL RESULTS OF STUDY C209
    Foster, G. R.
    Hezode, C.
    Bronowicki, J. -P.
    Carosi, G.
    Weiland, O.
    Verlinden, L.
    van Heeswijk, R.
    Van Baelen, B.
    Picchio, G.
    Beaumont-Mauviel, M.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S27 - S27
12345